Načítá se...
ABHD6: its place in endocannabinoid signaling and beyond.
The endocannabinoid (eCB) signaling system modulates neurotransmission and inflammation, amongst other physiological functions. Its newest member, α/β-hydrolase domain containing 6 (ABHD6), has emerged as a promising therapeutic target to treat several devastating diseases, including epilepsy. We re...
Uloženo v:
| Vydáno v: | Trends Pharmacol Sci |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445269/ https://ncbi.nlm.nih.gov/pubmed/30853109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2019.02.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|